Research Article
The Prediction and Prognostic Significance of INPP5K Expression in Patients with Liver Cancer
Table 2
Relationship between the clinical features of liver cancer and INPP5K expression.
| Parameter | Variables | | High | % | Low | % | X2 | | Fish |
| Age | <55 | 117 | 66 | (29.46) | 51 | (34.46) | 0.8127 | 0.3673 | 0.3615 | ≥55 | 255 | 158 | (70.54) | 97 | (65.54) | | | | Gender | Female | 121 | 75 | (33.33) | 46 | (31.08) | 0.1166 | 0.7327 | 0.7346 | Male | 252 | 150 | (66.67) | 102 | (68.92) | | | | Histological type | Fibrolamellar carcinoma | 3 | 3 | (1.33) | 0 | (0) | 3.9605 | 0.138 | 0.1695 | Hepatocellular carcinoma | 363 | 216 | (96) | 147 | (99.32) | | | | Hepatocholangiocarcinoma (mixed) | 7 | 6 | (2.67) | 1 | (0.68) | | | | Histologic grade | G1 | 55 | 38 | (17.19) | 17 | (11.56) | 4.21 | 0.2397 | 0.2344 | G2 | 178 | 110 | (49.77) | 68 | (46.26) | | | | G3 | 123 | 66 | (29.86) | 57 | (38.78) | | | | G4 | 12 | 7 | (3.17) | 5 | (3.4) | | | | Stage | I | 172 | 109 | (51.66) | 63 | (45.65) | 1.2996 | 0.7292 | 0.7014 | II | 87 | 51 | (24.17) | 36 | (26.09) | | | | III | 85 | 48 | (22.75) | 37 | (26.81) | | | | IV | 5 | 3 | (1.42) | 2 | (1.45) | | | | T classification | T1 | 182 | 115 | (51.57) | 67 | (45.27) | 2.2864 | 0.6832 | 0.7163 | T2 | 95 | 55 | (24.66) | 40 | (27.03) | | | | T3 | 80 | 45 | (20.18) | 35 | (23.65) | | | | T4 | 13 | 7 | (3.14) | 6 | (4.05) | | | | TX | 1 | 1 | (0.45) | 0 | (0) | | | | N classification | N0 | 253 | 150 | (66.96) | 103 | (69.59) | 0.5399 | 0.7634 | 0.6991 | N1 | 4 | 2 | (0.89) | 2 | (1.35) | | | | NX | 115 | 72 | (32.14) | 43 | (29.05) | | | | M classification | M0 | 267 | 159 | (70.67) | 108 | (72.97) | 0.4947 | 0.7809 | 0.7461 | M1 | 4 | 2 | (0.89) | 2 | (1.35) | | | | MX | 102 | 64 | (28.44) | 38 | (25.68) | | | | Radiation therapy | No | 340 | 208 | (97.65) | 132 | (97.78) | 0 | 1 | 1 | Yes | 8 | 5 | (2.35) | 3 | (2.22) | | | | Residual tumor | R0 | 326 | 198 | (90.41) | 128 | (87.07) | 2.7596 | 0.4302 | 0.4237 | R1 | 17 | 8 | (3.65) | 9 | (6.12) | | | | R2 | 1 | 0 | (0) | 1 | (0.68) | | | | RX | 22 | 13 | (5.94) | 9 | (6.12) | | | | Vital status | Deceased | 130 | 68 | (30.22) | 62 | (41.89) | 4.8529 | 0.0276 | 0.0262 | Living | 243 | 157 | (69.78) | 86 | (58.11) | | | | Sample type | Primary tumor | 371 | 225 | (100) | 146 | (98.65) | 1.0481 | 0.3059 | 0.1568 | Recurrent tumor | 2 | 0 | (0) | 2 | (1.35) | | | | Os_s | 0 | 237 | 154 | (69.37) | 83 | (57.24) | 5.1222 | 0.0236 | 0.0193 | 1 | 130 | 68 | (30.63) | 62 | (42.76) | | | | Rf_s | 0 | 179 | 125 | (64.1) | 54 | (43.2) | 12.668 | 0.0004 | 0.0003 | 1 | 141 | 70 | (35.9) | 71 | (56.8) | | | |
|
|